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Background: Diabetes Mellitus is a common chronic endocrine disorder of insulin secretion or function 
resulting in the disturbances of carbohydrate, fat and protein metabolism characterised by hyperglycemia. 
Cardiovascular complications are the most important cause of morbidity and mortality.
Objectives: To assess the pattern of cardiovascular risk among diabetic patients enrolling for the first care at the 
specialist clinic, and also determined the effects of the duration of DM on cardiovascular risk.
Method:  One hundred and fourteen asymptomatic people living with diabetes mellitus were evaluated 
considering time at first diagnosis of DM irrespective of the initial care given. Cardiovascular risk factors were 
compared in two groups based on the median year duration of DM. A further 6 sub-grouping was done to look at 
pattern of increase of the different CVD risk factors. 
Results: duration of DM range from 1-30 years, median of 5 years and modal of 1 year. There was a difference in 
the means of all CVD risk factors when subjected were divided into two groups based on the median age. Further 
sub-groupings of duration of DM showed significant differences in LVM, uric acid and creatinine.
Conclusions:  cardiovascular risk no doubt increases as the duration of DM increases and more significantly on 
the heart and the kidney. 
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 INTRODUCTION
Diabetes Mellitus (DM) is a common chronic 
endocrine disorder of insulin secretion or function 
resulting in the disturbances of carbohydrate, fats 
and protein metabolism characterised by 
hyperglycemia. Cardiovascular complications are 
the most important cause of morbidity and mortality 
expected to increase most in countries with the least 
1developed public health care systems .  
Epidemiological and clinical trial data have 
estimated that 60–70% of all patients with type 2 
2
diabetes will die from CVD . This is particularly 
challenging, as their CVD is more often 
asymptomatic. DM adds about 15 years in terms of 
cardiovascular risk compared to normal 
3
individuals . People living with diabetes under the 
age of 40 years are not particularly at high 
cardiovascular risk, however with time their 
cardiovascular risk increase because they are 
4
expected to have lived longer with DM . 
Duration of DM is a very important factor in the 
5development of cardiovascular complications . 
Clinical presentation in most cases is usually after 
development of a complication. For instance, overt 
nephropathy caused by glomerulosclerosis first 
appears 10-15years after the onset of insulin 
dependent DM (IDDM) and after 5-10years in 
patients with non-insulin dependent DM 
5,6
(NIDDM).  Duration of DM might give an idea of 
what complications is be present. Most patients 
present to the specialist clinic after having consulted 
several other treatment modalities ranging from self 
medication, faith based interventions, nearby 
chemists or laboratories.
This work ties to compare two groups of patients that 
presented to the specialist unit considering their 
duration of illness. The median value of duration of 
age was used as dividing point so as to get a 
proportionally equal no of subjects for analysis.  The 
possibility of a changing pattern or progression 
cardiovascular risk with respect to duration of 
disease should be of interest to any specialist.  
Methods
This was a cross sectional study among adults 
18years old or above, consecutively recruited while 
being evaluated on first specialist clinic visit at the 
medical out-patient clinic at the Jos University 
Teaching Hospital. All the patients consented and 
the study was approved by the Ethics Committee of 
the Jos University Teaching Hospital.
A questionnaire was used to obtain bio-data and 
relevant clinical history with durations and a general 
clinical examination was carried out on the subjects. 
Fasting plasma glucose, waist circumference and 
BMI were measured. Blood pressure (BP) was 
measured in the right arm with subjects in a seated 
and  r e l axed  pos i t ion  us ing  a  mercury  
sphygmomanometer. The first and fifth phases of the 
Korotkoff sounds were used for the systolic and 
diastolic blood pressure respectively.  
Laboratory analysis: Seven (7) mls of fasting venous 
blood sample was taken for serum electrolytes 
analysis. Serum lipids and uric acid were determined 
Ultrasonography: The carotid intima-media 
thickness of the far wall of proximal 10mm of the two 
common carotid arteries were determined using the 
8.0 MHz probe of real time B mode ultrasound 
imager (ALOKA SSD 4000 ultrasound system 
Japan). The average of four values (two from each 
side) was used for the study. A 3.5 MHz probe 
(ALOKA SSD 4000 ultrasound system Japan) was 
then used to obtain 2D guide M-mode left ventricular 
measurements through the left parasternal long axis 
view window for all subjects. Measurements were 
taken from leading edges. The Left ventricular mass 
was calculated using the Devereux formula.
Statistical analysis: Subjects were regrouped based 
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on the median of duration of DM, those with duration 
of diabetes for 5year or less and those with duration of 
diabetes for 6years and above. Those that were less 
than 1 year were approximated to be 1 year for 
analysis to be done in years.  Continuous variables 
were expressed as means + standard deviation (SD).   
Analysis was done with both Epi-info 3.5.1 and 
student T test was done to compare means of the two 
groups. A further regrouping was done.
Results 
A total data of 114 participants were analysed. 
Subjects were between the ages of 21 and 88 years. 
The total mean age was 55.29 + 14 years.
The subjects were mostly already on anti-diabetic 
agent/drug Metformin (70%), sulfonylurea 
Glibenclamide (52%), implying that most subjects 
were type 2 diabetics. The thiaozolidinediones and 
glucosidase inhibitors and other relatively newer 
anti-diabetic drugs were prescribed to very few 
subjects. Hypertension was the most common co-
morbidity (51%), and the most common anti-
hypertensive drugs taken by diabetic-hypertensive 
were  of the angiotensin receptor blockers (ARB) or 
angiotensin converting enzyme inhibitor(ACEI) 
(50%) group followed by Calcium channel blockers 
(30%). Diuretics were noted in 25% of subjects.
The duration of DM ranged from 1year to 30 years, 
with a mean of 6.99 + 5.97 years and median of 
th th
5years. The 25  and 75  quartiles were 2 and 10 years 
respectively. About 18% of subjects were diagnosed 
as having DM within a year. A comparative group 
with duration of DM less than 5 years and 6 years and 
above  i s  shown on  tab le  1 .  S imi la r ly  
echocardiography findings were compared as shown 
in table 2.  Another regrouping is shown in table 3.
Table . CLINICAL CHARECTERISTICS OF DM PATIENT WITH DURATION OF DM LESS 
THAN 6 YEAR AND ABOVE 5 YEARS
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Table . CLINICAL CHARACTERISTICS OF DM PATIENT WITH DURATION OF DM 
LESS THAN 6 YEARS AND ABOVE 5 YEARS
 
Table . RISK FACTORS IN DIFFERENT GROUPINGS OF DURATION OF DM
Keys; WC- waist circumference, SBP- systolic blood 
pressure, DBP- diastolic blood pressure, LVM- left 
ventricular mass CIMT- carotid intima-media 
thickness, UA uric acid, chol T- total cholesterol, 
HDL- high dense lipoprotein, FBS- fasting blood 
sugar, Cr- createnin. P-value was significant (*) 
DISCUSSIONS
We sought to determine cardiovascular risk among 
diabetic patients presenting for their first specialist 
visit. It was observed that 41% of patients had been 
diagnosed with DM more than 5years prior to first 
specialist visit. This finding may appear disturbing 
considering the fact that most diabetes mellitus 
patients have been reported to have complications as 
7,8at the time of diagnosis.  Specialist evaluation may 
be urgently needed to evaluate some of these 
complications. It therefore means interventions could 
be delayed with grave consequences.   This may not 
necessarily be entirely true because some subjects 
may have been accessing health care at primary and 
secondary health care levels with satisfaction. It is 
logical that patients with long duration of DM were 
significantly older than the younger group. 
Hypertension was seen to be associated with DM in 
51% of all cases and in more than 50% in both groups. 
We however did not ascertain if hypertension 
preceded DM or the other way round. The use of 
diuretics was noted in 25% of subjects for blood 
pressure control. The thiazide diuretics and beta 
blockers have been known to affect carbohydrate 
10metabolism subjecting patient to DM.   
 In order to demonstrate increasing pattern, we 
needed to compare groups of individuals at different 
stages of the disease. Considering the skewed pattern 
of distribution of subjects, the median value 5 years 
duration of DM was taken as dividing point to get two 
groups for comparism. It was obvious these 
asymptomatic people having to live longer with DM 
have more severe cardiovascular risk. When we 
looked further at the echocardiographic findings 
between these two groups, the observation was 
13
similar. Studies like that of Osunkwo  had 
demonstrated that microangiopathy (CVD risk) is 
strongly associated with duration of DM, a finding 
12,14consistent with ours. Danbauchi et al  also 
demonstrated left ventricular abnormality in DM 
patients. To further demonstrate the pattern with 
which each of this cardiovascular risk increases, in 
other words the rapidity with which these factors 
increase. A further sub-grouping of duration of DM 
was compared with the similar group of 
cardiovascular risks. The rapidity with which these 
risk factors increase varies. Statistically however, 
there were differences in the means of CVD risk in the 
two groupings using the student t-test and differences 
in means of LVM, UA and creatinine. Objectively, 
looking at the values of level of significance (p-value) 
it appears the degree of increasing risk varies with the 
type of cardiovascular risk. These could suggest rapid 
renal and cardiac complication in symptomatic DM 
subjects.
Limitations: The therapy these subjects had before 
presenting to the specialist clinic could have altered 
our findings and a prospective study will be ideal for 
this kind of study. The proportions of subjects in the 
different groupings varied greatly making 
comparisms less ideal. 
Conclusion: Most cardiovascular risks steadily rise 
as the duration of DM gets longer and findings 
suggested a higher prevalence of heart and renal 
complications as DM progresses in this environment.
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